[CLDX] QoQ Quarter Result on 31-Mar-2017 [#Q1]

Stock
[CLDX] Celldex Therapeutics, Inc.
Announcement Date
09-May-2017
Financial Year
2017
Quarter
31-Mar-2017 [#Q1]
Profit Trend
QoQ- -6.05%
YoY- 1.19%
Quarter Report
CLDX's Result
CLDX's Financial Summary
View:
Show?
Quarter Result
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
Revenue 3,456 3,924 3,829 1,534 1,874 2,220 1,389 83.31%
PBT -22,923 -31,563 -28,566 -34,261 -32,307 -29,598 -31,952 -19.81%
Tax -19,082 -5,200 1,276 5,098 -5,090 -790 -828 705.21%
NP -3,841 -26,363 -28,566 -34,261 -32,307 -29,598 -31,952 -75.54%
Tax Rate - - - - - - - -
Total Cost 7,297 30,287 32,395 35,795 34,181 31,818 33,341 -63.58%
Ratio Analysis
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
NP Margin -111.14 -671.84 -746.04 -2,233.44 -1,723.96 -1,333.24 -2,300.36 -86.66%
Per Share
31/12/17 30/09/17 30/06/17 31/03/17 31/12/16 30/09/16 30/06/16 CAGR
EPS -0.42 -3.05 -3.42 -4.19 -4.49 -4.41 -4.85 -80.33%
EPS Diluted -0.41 -3.05 -3.42 -4.19 -4.49 -4.41 -4.85 -80.65%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.